title: Can liberating p53 from E6 free patients from HPV-related head and neck tumors?
authors: Laboratoire de Biologie Tumorale, Centre Régional de Lutte Contre le Cancer Paul Strauss, Strasbourg, France. ajung@strasbourg.unicancer.fr
authors: Alain C
authors: AC
authors: Jung
mesh_terms: D002294:Carcinoma, Squamous Cell / Q000378:metabolism*; D050759:Cyclin-Dependent Kinase Inhibitor p21 / Q000378:metabolism*; D006258:Head and Neck Neoplasms / Q000378:metabolism*; D006801:Humans; D009856:Oncogene Proteins, Viral / Q000235:genetics*; D050725:Papillomavirus E7 Proteins / Q000235:genetics*; D012097:Repressor Proteins / Q000235:genetics*; D000077195:Squamous Cell Carcinoma of Head and Neck; D016159:Tumor Suppressor Protein p53 / Q000378:metabolism*
chemical_list: D050759:Cyclin-Dependent Kinase Inhibitor p21; C068651:E6 protein, Human papillomavirus type 16; D009856:Oncogene Proteins, Viral; D050725:Papillomavirus E7 Proteins; D012097:Repressor Proteins; D016159:Tumor Suppressor Protein p53; C059731:oncogene protein E7, Human papillomavirus type 16
keywords: Bortezomib; E6; HPV; Head and Neck Squamous Cell Carcinoma; apoptosis; cell cycle arrest; p21; p53